World Café approach: exploring the future vision of oral anticoagulants for patients with atrial fibrillation (AF) in Ireland
Autor: | Paidi O'Raghallaigh, Stephen Brosnan, Colin P Bradley, Stephen McCarthy, Ann Kirby, Aileen Murphy |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
medicine.medical_specialty
protocols & guidelines medicine.drug_class Administration Oral Cardiovascular Medicine adult cardiology Atrial Fibrillation medicine Effective treatment Humans Intensive care medicine Physician-Patient Relations business.industry Anticoagulant Warfarin Anticoagulants Atrial fibrillation General Medicine medicine.disease Focus group Integrated care Stroke Facilitator stroke medicine Medicine business Ireland qualitative research medicine.drug Qualitative research |
Zdroj: | BMJ Open BMJ Open, Vol 10, Iss 9 (2020) |
ISSN: | 2044-6055 |
Popis: | ObjectivesTo explore and reflect on the current anticoagulation therapy offered to patients with atrial fibrillation (AF), potential challenges and the future vision for oral anticoagulants for patients with AF and healthcare professionals in Ireland.DesignA multistakeholder focus group using a World Café approach.ParticipantsNine participants from academic, clinical and health backgrounds attended the focus group together with a facilitator.ResultsEnhanced patient empowerment; more effective use of technology and developing system-based medical care pathways would provide improved supports for AF management. The challenges in providing these include cost and access issues, the doctor–patient relationship and the provision of education. While consensus for developing evidence-based pathways to maximise efficiency and effectiveness of AF treatment was evident, it would require a shared vision between stakeholders of integrated care. The benefits of embracing technological advances for clinicians and patients were evident; however, clinicians indicate this can increase pressure on already stretched resources; coupled with institutional barriers (including scarce resources) arising from the complex nature of anticoagulation for patients with AF, which emerged strongly. Including the unpredictable nature of warfarin, hidden costs associated with monitoring, adverse clinical effects, different patient cohorts (including those prescribed anticoagulant for the first time vs those switching from warfarin to a new oral anticoagulant (NOAC)), non-adherence concerns and undesirable impacts on patients’ daily lives.ConclusionsWhile anticoagulation therapy for patients with AF using NOACs has been widely adopted and is diffusing into routine practice, significant operationalisation issues and barriers to effective treatment/management persist. The reflections reported in this study are a catalyst for future discussion and research. |
Databáze: | OpenAIRE |
Externí odkaz: |